RAB22A and gastric cancer: Li et al. showed that miR-26a-5p could impede proliferation and the invasion of GC cells by targeting COL10A1 [20] Zhang et al. demonstrated that miR-204a-5p functioned as an oncogene by targeting USP47 and RAB22A in stomach cancer [21].